For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.





Elizabeth Warren and a host of Democratic lawmakers are demanding the Obama administration stand up for gay rights.

A coalition of 80 senators and House members spearheaded by the Massachusetts senator—alongside Sens. Tammy Baldwin (D-Wis.) and Tom Harkin (D-Iowa) and Reps. Mike Quigley (D-Ill.) and Barbara Lee (D-Calif.)—sent a letter Monday to Sylvia Burwell, secretary of the Department of Health and Human Services, protesting the long-standing prohibition that bars men who have had sex with men from donating blood in the United States.

In 1983, the federal government instituted a lifetime ban for any man who has had sex with another man—even once—at any time after 1977. That rule went into effect during the early days of AIDS panic when the disease was largely unknown. Now, technology exists that can detect HIV within a few weeks of infection.

Last month, an HHS panel that handles blood policy advocated tossing out the lifetime ban—but argued for replacing it with a measure that would keep any sexually active gay man from contributing to the blood supply: a ban on donations from any man who had sex with another man within the past year.

To the Democrats in Congress, that slight improvement isn’t nearly enough. The letter calls both the lifetime ban and the one-year deferral policies “discriminatory” and “unacceptable.” The lawmakers urged an end to the lifetime ban by the “end of 2014,” while also pushing for a less-stringent restriction than the one-year celibacy requirement.

“The recommendation to move to a one-year deferral policy is a step forward relative to current policies; however, such a policy still prevents many low-risk individuals from donating blood,” the letter says. “If we are serious about protecting and enhancing our nation’s blood supply, we must embrace science and reject outdated stereotypes.”

The letter may have been better directed at the Food and Drug Administration. That agency’s Blood Products Advisory Panel met earlier this month to consider the one-year deferral proposed by HHS, but the panel of experts seemed more inclined to let the current policy stand rather than loosen the restrictions.

Here’s the full letter: